{"id":"https://openalex.org/W4283698722","doi":"https://doi.org/10.1182/bloodadvances.2022007046","title":"The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade","display_name":"The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade","publication_year":2022,"publication_date":"2022-06-29","ids":{"openalex":"https://openalex.org/W4283698722","doi":"https://doi.org/10.1182/bloodadvances.2022007046","pmid":"https://pubmed.ncbi.nlm.nih.gov/35767735","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9636403"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2022007046","doi":"https://doi.org/10.1182/bloodadvances.2022007046","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2022007046","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/6/15/4634/1912503/advancesadv2022007046.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ashpublications.org/bloodadvances/article-pdf/6/15/4634/1912503/advancesadv2022007046.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058172577","display_name":"Valentina Tabanelli","orcid":"https://orcid.org/0000-0002-4142-2248","observed_orcids":["https://orcid.org/0000-0002-4142-2248"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Valentina Tabanelli","raw_affiliation_strings":["1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;"],"raw_orcid":"https://orcid.org/0000-0002-4142-2248","affiliations":[{"raw_affiliation_string":"1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011647120","display_name":"Federica Melle","orcid":"https://orcid.org/0000-0002-5541-2673","observed_orcids":["https://orcid.org/0000-0002-5541-2673"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Melle","raw_affiliation_strings":["1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015082674","display_name":"Giovanna Motta","orcid":"https://orcid.org/0000-0001-5593-5397","observed_orcids":["https://orcid.org/0000-0001-5593-5397"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanna Motta","raw_affiliation_strings":["1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;"],"raw_orcid":"https://orcid.org/0000-0001-5593-5397","affiliations":[{"raw_affiliation_string":"1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064979240","display_name":"Saveria Mazzara","orcid":"https://orcid.org/0000-0003-1799-2360","observed_orcids":["https://orcid.org/0000-0003-1799-2360"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Saveria Mazzara","raw_affiliation_strings":["1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048050903","display_name":"Marco Fabbri","orcid":"https://orcid.org/0000-0002-7056-4691","observed_orcids":["https://orcid.org/0000-0002-7056-4691"]},"institutions":[{"id":"https://openalex.org/I4210118689","display_name":"Joint Research Centre","ror":"https://ror.org/02qezmz13","country_code":"IT","type":"government","lineage":["https://openalex.org/I1320481043","https://openalex.org/I2800387288","https://openalex.org/I4210118689","https://openalex.org/I4210161702"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Fabbri","raw_affiliation_strings":["2European Commission, Joint Research Centre (JRC), Ispra, Italy;"],"raw_orcid":"https://orcid.org/0000-0002-7056-4691","affiliations":[{"raw_affiliation_string":"2European Commission, Joint Research Centre (JRC), Ispra, Italy;","institution_ids":["https://openalex.org/I4210118689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102850085","display_name":"Claudio Agostinelli","orcid":"https://orcid.org/0000-0002-4945-1422","observed_orcids":["https://orcid.org/0000-0002-4945-1422"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Claudio Agostinelli","raw_affiliation_strings":["3Haematopathology Unit, IRCCS Azienda Ospedaliero\u2013Universitaria di Bologna, Bologna, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Haematopathology Unit, IRCCS Azienda Ospedaliero\u2013Universitaria di Bologna, Bologna, Italy;","institution_ids":["https://openalex.org/I4210097083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062143718","display_name":"Angelica Calleri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Angelica Calleri","raw_affiliation_strings":["1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Marcello Del Corvo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marcello Del Corvo","raw_affiliation_strings":["1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104101717","display_name":"Stefano Fiori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefano Fiori","raw_affiliation_strings":["1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070936189","display_name":"Daniele Lorenzini","orcid":"https://orcid.org/0000-0002-1425-3354","observed_orcids":["https://orcid.org/0000-0002-1425-3354"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniele Lorenzini","raw_affiliation_strings":["1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050588157","display_name":"Alessandra Cesano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099129","display_name":"Nanostring Technologies (United States)","ror":"https://ror.org/00xzdzk88","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099129"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alessandra Cesano","raw_affiliation_strings":["4NanoString Technologies, Inc., Seattle, WA;","5ESSA Pharma, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4NanoString Technologies, Inc., Seattle, WA;","institution_ids":["https://openalex.org/I4210099129"]},{"raw_affiliation_string":"5ESSA Pharma, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054623894","display_name":"Annalisa Chiappella","orcid":"https://orcid.org/0000-0002-2977-0098","observed_orcids":["https://orcid.org/0000-0002-2977-0098"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Annalisa Chiappella","raw_affiliation_strings":["6Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;"],"raw_orcid":"https://orcid.org/0000-0002-2977-0098","affiliations":[{"raw_affiliation_string":"6Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000403848","display_name":"Umberto Vitolo","orcid":"https://orcid.org/0000-0001-7772-2747","observed_orcids":["https://orcid.org/0000-0001-7772-2747"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Umberto Vitolo","raw_affiliation_strings":["7Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy;"],"raw_orcid":"https://orcid.org/0000-0001-7772-2747","affiliations":[{"raw_affiliation_string":"7Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002306207","display_name":"Enrico Derenzini","orcid":"https://orcid.org/0000-0002-7154-8140","observed_orcids":["https://orcid.org/0000-0002-7154-8140"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Enrico Derenzini","raw_affiliation_strings":["8Onco-Hematology Unit, European Institute of Oncology, IRCCS, Milan, Italy;","9Department of Health Sciences, University of Milan, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Onco-Hematology Unit, European Institute of Oncology, IRCCS, Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]},{"raw_affiliation_string":"9Department of Health Sciences, University of Milan, Milan, Italy;","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103149392","display_name":"Gabriel Kenneth Griffin","orcid":"https://orcid.org/0000-0002-4042-6757","observed_orcids":["https://orcid.org/0000-0002-4042-6757","https://orcid.org/0009-0006-0185-1239"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel K. Griffin","raw_affiliation_strings":["10Department of Pathology, Dana-Farber Cancer Institute, Boston, MA; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Department of Pathology, Dana-Farber Cancer Institute, Boston, MA; and","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058975989","display_name":"Scott J. Rodig","orcid":"https://orcid.org/0000-0003-1761-9769","observed_orcids":["https://orcid.org/0000-0003-1761-9769"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott J. Rodig","raw_affiliation_strings":["11Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007978440","display_name":"Anna Vanazzi","orcid":"https://orcid.org/0000-0002-2977-4208","observed_orcids":["https://orcid.org/0000-0002-2977-4208"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Vanazzi","raw_affiliation_strings":["8Onco-Hematology Unit, European Institute of Oncology, IRCCS, Milan, Italy;"],"raw_orcid":"https://orcid.org/0000-0002-2977-4208","affiliations":[{"raw_affiliation_string":"8Onco-Hematology Unit, European Institute of Oncology, IRCCS, Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060227300","display_name":"Elena Sabattini","orcid":"https://orcid.org/0000-0002-4136-3591","observed_orcids":["https://orcid.org/0000-0002-4136-3591"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Sabattini","raw_affiliation_strings":["3Haematopathology Unit, IRCCS Azienda Ospedaliero\u2013Universitaria di Bologna, Bologna, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Haematopathology Unit, IRCCS Azienda Ospedaliero\u2013Universitaria di Bologna, Bologna, Italy;","institution_ids":["https://openalex.org/I4210097083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058765211","display_name":"Corrado Tarella","orcid":"https://orcid.org/0000-0003-1473-6046","observed_orcids":["https://orcid.org/0000-0003-1473-6046"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Corrado Tarella","raw_affiliation_strings":["8Onco-Hematology Unit, European Institute of Oncology, IRCCS, Milan, Italy;","9Department of Health Sciences, University of Milan, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Onco-Hematology Unit, European Institute of Oncology, IRCCS, Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]},{"raw_affiliation_string":"9Department of Health Sciences, University of Milan, Milan, Italy;","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073222946","display_name":"Maria Rosaria Sapienza","orcid":"https://orcid.org/0000-0002-1078-2128","observed_orcids":["https://orcid.org/0000-0002-1078-2128"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Rosaria Sapienza","raw_affiliation_strings":["1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;"],"raw_orcid":"https://orcid.org/0000-0002-1078-2128","affiliations":[{"raw_affiliation_string":"1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043985252","display_name":"Stefano Aldo Pileri","orcid":"https://orcid.org/0000-0001-8032-5128","observed_orcids":["https://orcid.org/0000-0001-8032-5128"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefano A. Pileri","raw_affiliation_strings":["1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Haematopathology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5058172577"],"corresponding_institution_ids":["https://openalex.org/I6141010"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":3.0158,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.92762117,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"6","issue":"15","first_page":"4634","last_page":"4644"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6563000082969666,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6563000082969666,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.32280001044273376,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-histiocyte-rich-large-b-cell-lymphoma","display_name":"T-cell/histiocyte-rich large B-cell lymphoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.8960000276565552},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.949999988079071},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.7310000061988831},{"id":"https://openalex.org/keywords/gene-co-expression-network","display_name":"gene co-expression network","score":0.7059999704360962},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.8840000033378601},{"id":"https://openalex.org/keywords/tcf1","display_name":"TCF1","score":0.5370000004768372},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.8523191213607788},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.7238748073577881},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.6600054502487183},{"id":"https://openalex.org/C15729860","wikidata":"https://www.wikidata.org/wiki/Q2329919","display_name":"Progenitor","level":4,"score":0.46820738911628723},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.38808226585388184},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3673717975616455},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.3597240746021271},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34304893016815186},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3256336450576782},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.313479483127594},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13177654147148132},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006644","descriptor_name":"Histiocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006644","descriptor_name":"Histiocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051538","descriptor_name":"Hepatocyte Nuclear Factor 1-alpha","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1182/bloodadvances.2022007046","doi":"https://doi.org/10.1182/bloodadvances.2022007046","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2022007046","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/6/15/4634/1912503/advancesadv2022007046.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9636403","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9636403","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:35767735","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35767735","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"},{"id":"pmh:oai:air.unimi.it:2434/941025","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2434/941025","pdf_url":"https://air.unimi.it/bitstream/2434/941025/2/advancesadv2022007046.pdf","source":{"id":"https://openalex.org/S4306400516","display_name":"Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I189158943","host_organization_name":"University of Milan","host_organization_lineage":["https://openalex.org/I189158943"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:cris.unibo.it:11585/905986","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11585/905986","pdf_url":null,"source":{"id":"https://openalex.org/S4306402579","display_name":"Archivio istituzionale della ricerca (Alma Mater Studiorum Universit\u00e0 di Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210117483","host_organization_name":"Istituto di Ematologia di Bologna","host_organization_lineage":["https://openalex.org/I4210117483"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2022007046","doi":"https://doi.org/10.1182/bloodadvances.2022007046","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2022007046","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/6/15/4634/1912503/advancesadv2022007046.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G2406870047","display_name":null,"funder_award_id":"#21198","funder_id":"https://openalex.org/F4320323054","funder_display_name":"Associazione Italiana per la Ricerca sul Cancro"}],"funders":[{"id":"https://openalex.org/F4320323054","display_name":"Associazione Italiana per la Ricerca sul Cancro","ror":"https://ror.org/02g2x7380"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283698722.pdf","grobid_xml":"https://content.openalex.org/works/W4283698722.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1573738438","https://openalex.org/W1605230984","https://openalex.org/W1992355310","https://openalex.org/W1996212620","https://openalex.org/W2009892803","https://openalex.org/W2040353461","https://openalex.org/W2053751264","https://openalex.org/W2063067513","https://openalex.org/W2104966044","https://openalex.org/W2112680373","https://openalex.org/W2136850043","https://openalex.org/W2150382709","https://openalex.org/W2151452389","https://openalex.org/W2157459709","https://openalex.org/W2201306698","https://openalex.org/W2345356016","https://openalex.org/W2558219863","https://openalex.org/W2566018578","https://openalex.org/W2612431515","https://openalex.org/W2655262992","https://openalex.org/W2744261860","https://openalex.org/W2805479364","https://openalex.org/W2899145148","https://openalex.org/W2903754922","https://openalex.org/W2928665623","https://openalex.org/W2977605642","https://openalex.org/W2987502752","https://openalex.org/W3043369050","https://openalex.org/W3078201066","https://openalex.org/W3082188955","https://openalex.org/W3091946463","https://openalex.org/W3097831415","https://openalex.org/W3135289633","https://openalex.org/W3153135411","https://openalex.org/W3182123867","https://openalex.org/W3198679689"],"related_works":["https://openalex.org/W2910468905","https://openalex.org/W2984622414","https://openalex.org/W7117466558","https://openalex.org/W4249037172","https://openalex.org/W2949335654","https://openalex.org/W2911487711","https://openalex.org/W3082188955","https://openalex.org/W2985295321","https://openalex.org/W4285386927","https://openalex.org/W2986516670"],"abstract_inverted_index":{"T-cell/histiocyte-rich":[0,53],"large":[1,13],"B-cell":[2,14],"lymphoma":[3,15],"(THRLBCL)":[4],"is":[5,60],"a":[6,34,51,82,215,232],"rare":[7],"and":[8,67,71,105,121,125,191,271],"aggressive":[9],"variant":[10],"of":[11,58,81,99,118,144,161,174,182,234,257,275],"diffuse":[12],"(DLBCL)":[16],"that":[17,201],"usually":[18],"affects":[19],"young":[20],"to":[21,40,62,72,178,206,213,267],"middle-aged":[22],"patients,":[23],"with":[24,253,263,280],"disseminated":[25],"disease":[26],"at":[27],"presentation.":[28],"The":[29,194],"tumor":[30],"microenvironment":[31],"(TME)":[32],"plays":[33],"key":[35],"role":[36,143],"in":[37,50,102,130,133,158,218,251,278],"THRLBCL":[38,59,103,120,186,202,220],"due":[39],"its":[41],"peculiar":[42],"cellular":[43],"composition":[44],"(<10%":[45],"neoplastic":[46],"B":[47],"cells":[48,101,249,261],"interspersed":[49],"cytotoxic":[52],"background).":[54],"A":[55],"significant":[56],"percentage":[57],"refractory":[61],"rituximab,":[63],"cyclophosphamide,":[64],"doxorubicin,":[65],"vincristine,":[66],"prednisone":[68],"(RCHOP)-based":[69],"regimens":[70],"chimeric":[73],"antigen":[74],"receptor":[75],"T-cell":[76],"therapy;":[77],"thus,":[78],"the":[79,97,113,141,145,159,162,166,172,179,243],"development":[80],"specific":[83],"therapeutic":[84,109,223],"approach":[85],"for":[86],"these":[87],"patients":[88,252,279],"represents":[89],"an":[90,131],"unmet":[91],"clinical":[92,265],"need.":[93],"To":[94],"better":[95],"understand":[96],"interaction":[98],"immune":[100,114,163,195,268],"TME":[104,187],"identify":[106],"more":[107],"promising":[108],"strategies,":[110],"we":[111,225],"compared":[112],"gene":[115,196],"expression":[116],"profiles":[117],"12":[119],"10":[122],"DLBCL":[123],"samples,":[124],"further":[126],"corroborated":[127],"our":[128,227],"findings":[129,198],"extended":[132],"silico":[134],"set.":[135],"Gene":[136],"coexpression":[137],"network":[138],"analysis":[139],"identified":[140],"predominant":[142],"programmed":[146],"cell":[147,152],"death":[148,153],"protein":[149],"1":[150,155],"(PD-1)/programmed":[151],"ligand":[154],"(PD-L1)":[156],"axis":[157],"modulation":[160],"response.":[164],"Furthermore,":[165],"PD-1/PD-L1":[167],"activation":[168],"was":[169,188],"flanked":[170],"by":[171,229,242],"overexpression":[173],"48":[175],"genes":[176],"related":[177],"functional":[180],"exhaustion":[181],"T":[183,248,260],"cells.":[184],"Globally,":[185],"highly":[189],"interferon-inflamed":[190],"severely":[192],"exhausted.":[193],"profiling":[197],"strongly":[199],"suggest":[200],"may":[203,272],"be":[204],"responsive":[205],"anti-PD-1":[207,276],"therapy":[208,270],"but":[209],"also":[210],"allowed":[211],"us":[212],"take":[214],"step":[216],"forward":[217],"understanding":[219],"TME.":[221],"Of":[222],"relevance,":[224],"validated":[226],"results":[228],"immunohistochemistry,":[230],"identifying":[231],"subset":[233,256],"TCF1+":[235,258],"(T":[236],"cell-specific":[237],"transcription":[238],"factor":[239],"1,":[240],"encoded":[241],"TCF7":[244],"gene)":[245],"progenitor":[246],"exhausted":[247,259],"enriched":[250],"THRLBCL.":[254,281],"This":[255],"correlates":[262],"good":[264],"response":[266,277],"checkpoint":[269],"improve":[273],"prediction":[274]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-30T00:00:00"}